Erratum: 2-isoxazol-3-phenyltropane derivatives of cocaine: Molecular and atypical system effects at the dopamine transporter (Journal of Pharmacology and Experimental Therapeutics (2014) 349 (297-309) DOI:10.1124/jpet.113.212738);2-Isoxazol-3-Phenyltropane derivatives of Cocaine: Molecular and Atypical system effects at the Dopamine Transporter

Journal of Pharmacology and Experimental Therapeutics

Volumn 349, Issue 2, 2014, Pages 297-309

  Hiranita, Takato ^a   Wilkinson, Derek S ^a   Hong, Weimin C ^b   Zou, Mu Fa ^c   Kopajtic, Theresa A ^a   Soto, Paul L ^d   Lupica, Carl R ^a   Newman, Amy H ^c   Katz, Jonathan L ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b Cellular Pathobiology Section   (United States)

^c Medicinal Chemistry   (United States)

^d TEXAS TECH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA(4 CHLOROPHENYL) 2BETA[3 (4 METHYLPHENYL) ISOXAZOL 5 YL]TROPANE; 3BETA(4 METHYLPHENYL) 2BETA[3 (4 CHLOROPHENYL) ISOXAZOL 5 YL]TROPANE; CANNABINOID 1 RECEPTOR; COCAINE; COCAINE DERIVATIVE; DOPAMINE TRANSPORTER; DRUGS USED IN THE TREATMENT OF ADDICTION; MUSCARINIC M1 RECEPTOR; NORADRENALIN TRANSPORTER; RTI 336; RTI 371; SEROTONIN TRANSPORTER; SIGMA 1 OPIATE RECEPTOR; SIGMA 2 OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; IN VIVO STUDY; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONFORMATION; RAT; RECEPTOR BINDING ASSAY; SELF ADMINISTRATION TEST;

ANIMALS; COCAINE; CORPUS STRIATUM; DISCRIMINATION (PSYCHOLOGY); DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; HEK293 CELLS; HUMANS; ISOXAZOLES; MALE; MICE; MICE, MUTANT STRAINS; MODELS, MOLECULAR; MOTOR ACTIVITY; PROTEIN CONFORMATION; RADIOLIGAND ASSAY; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; SELF ADMINISTRATION; TROPANES;

EID: 84898008454     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.114.06er14a     Document Type: Erratum

References (47)

1. Bergman J, Madras BK, Johnson SE, and Spealman RD (1989) Effects of cocaine and related drugs in nonhuman primates. III. Self-Administration by squirrel monkeys. J Pharmacol Exp Ther 251:150-155
2. Campbell VC, Kopajtic TA, Newman AH, and Katz JL (2005) Assessment of the influence of histaminergic actions on cocaine-like effects of 3alpha-diphenylmethoxytropane analogs. J Pharmacol Exp Ther 315:631-640
3. Carroll FI, Fox BS, Kuhar MJ, Howard JL, Pollard GT, and Schenk S (2006a) Effects of dopamine transporter selective 3-phenyltropane analogs on locomotor activity, drug discrimination, and cocaine self-Administration after oral administration. Eur J Pharmacol 553:149-156
4. Carroll FI, Howard JL, Howell LL, Fox BS, and Kuhar MJ (2006b) Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse. AAPS J 8:E196-E203
5. Carroll FI, Pawlush N, Kuhar MJ, Pollard GT, and Howard JL (2004) Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3beta-(substituted phenyl)-2beta-(39-substituted isoxazol-5-yl)tropanes. J Med Chem 47:296-302
6. Czoty PW, Martelle JL, Carroll FI, and Nader MA (2010) Lower reinforcing strength of the phenyltropane cocaine analogs RTI-336 and RTI-177 compared to cocaine in nonhuman primates. Pharmacol Biochem Behav 96:274-278
7. Desai RI, Kopajtic TA, French D, Newman AH, and Katz JL (2005a) Relationship between in vivo occupancy at the dopamine transporter and behavioral effects of cocaine, GBR 12909 [1-2-[bis-(4-fluorophenyl)methoxy] ethyl-4-(3-phenylpropyl) piperazine], and benztropine analogs. J Pharmacol Exp Ther 315:397-404
8. Desai RI, Kopajtic TA, Koffarnus M, Newman AH, and Katz JL (2005b) Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine. J Neurosci 25:1889-1893
9. Dews PB (1953) The measurement of the influence of drugs on voluntary activity in mice. Br Pharmacol Chemother 8:46-48
10. Dews PB (1958) Studies on behavior. IV. Stimulant actions of methamphetamine. J Pharmacol Exp Ther 122:137-147
11. Garcés-Ramírez L, Green JL, Hiranita T, Kopajtic TA, Mereu M, Thomas AM, Mesangeau C, Narayanan S, McCurdy CR, and Katz JL, et al. (2011) Sigma receptor agonists: receptor binding and effects on mesolimbic dopamine neurotransmission assessed by microdialysis. Biol Psychiatry 69:208-217
12. Haile CN, Zhang XY, Carroll FI, and Kosten TA (2005) Cocaine self-Administration and locomotor activity are altered in Lewis and F344 inbred rats by RTI 336, a 3-phenyltropane analog that binds to the dopamine transporter. Brain Res 1055: 186-195
13. Hiranita T, Kohut SJ, Soto PL, Tanda G, Kopajtic TA, and Katz JL (2014) Preclinical efficacy of N-substituted benztropine analogs as antagonists of methamphetamine self-Administration in rats. J Pharmacol Exp Ther 348:174-191
14. Hiranita T, Soto PL, Kohut SJ, Kopajtic T, Cao J, Newman AH, Tanda G, and Katz JL (2011) Decreases in cocaine self-Administration with dual inhibition of the dopamine transporter and s receptors. J Pharmacol Exp Ther 339:662-677
15. Hiranita T, Soto PL, Newman AH, and Katz JL (2009) Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-Administration in rats: comparisons with monoamine uptake inhibitors. J Pharmacol Exp Ther 329: 677-686
16. Hong WC and Amara SG (2010) Membrane cholesterol modulates the outward facing conformation of the dopamine transporter and alters cocaine binding. J Biol Chem 285:32616-32626
17. Howell LL, Carroll FI, Votaw JR, Goodman MM, and Kimmel HL (2007) Effects of combined dopamine and serotonin transporter inhibitors on cocaine selfadministration in rhesus monkeys. J Pharmacol Exp Ther 320:757-765
18. Howell LL, Czoty PW, Kuhar MJ, and Carrol FI (2000) Comparative behavioral pharmacology of cocaine and the selective dopamine uptake inhibitor RTI-113 in the squirrel monkey. J Pharmacol Exp Ther 292:521-529
19. Husbands SM, Izenwasser S, Kopajtic T, Bowen WD, Vilner BJ, Katz JL, and Newman AH (1999) Structure-Activity relationships at the monoamine transporters and sigma receptors for a novel series of 9-[3-(cis-3, 5-dimethyl-1-piperazinyl) propyl]carbazole (rimcazole) analogues. J Med Chem 42:4446-4455
20. Katz JL and Higgins ST (2003) The validity of the reinstatement model of craving and relapse to drug use. Psychopharmacology (Berl) 168:21-30
21. Katz JL, Izenwasser S, and Terry P (2000) Relationships among dopamine transporter affinities and cocaine-like discriminative-stimulus effects. Psychopharmacology (Berl) 148:90-98
22. Katz JL, Kopajtic TA, Agoston GE, and Newman AH (2004) Effects of N-substituted analogs of benztropine: diminished cocaine-like effects in dopamine transporter ligands. J Pharmacol Exp Ther 309:650-660
23. Kimmel HL, Negus SS, Wilcox KM, Ewing SB, Stehouwer J, Goodman MM, Votaw JR, Mello NK, Carroll FI, and Howell LL (2008) Relationship between rate of drug uptake in brain and behavioral pharmacology of monoamine transporter inhibitors in rhesus monkeys. Pharmacol Biochem Behav 90:453-462
24. Kimmel HL, O'Connor JA, Carroll FI, and Howell LL (2007) Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys. Pharmacol Biochem Behav 86:45-54
25. Lees A (2005) Alternatives to levodopa in the initial treatment of early Parkinson's disease. Drugs Aging 22:731-740
26. Li L, Hiranita T, Hayashi S, Newman AH, and Katz JL (2013) The stereotypyinducing effects of N-substituted benztropine analogs alone and in combination with cocaine do not account for their blockade of cocaine self-Administration. Psychopharmacology (Berl) 225:733-742
27. Li SM, Kopajtic TA, O'Callaghan MJ, Agoston GE, Cao J, Newman AH, and Katz JL (2011) N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effects. J Pharmacol Exp Ther 336:575-585
28. Loland CJ, Desai RI, Zou MF, Cao J, Grundt P, Gerstbrein K, Sitte HH, Newman AH, Katz JL, and Gether U (2008) Relationship between conformational changes in the dopamine transporter and cocaine-like subjective effects of uptake inhibitors. Mol Pharmacol 73:813-823
29. McKearney JW (1982) Stimulant actions of histamine H1 antagonists on operant behavior in the squirrel monkey. Psychopharmacology (Berl) 77:156-158
30. Middaugh LD, McGroarty KK, Groseclose CH, and Adinoff B (1998) Cocaine discrimination: relationship to local anesthetics and monoamine uptake inhibitors in C57BL/6 mice. Psychopharmacology (Berl) 136:44-49
31. Navarro HA, Howard JL, Pollard GT, and Carroll FI (2005) The DAT-selective 3-phenyltropane, RTI-371, antagonizes the in vivo effects of cocaine. 67th Annual Meeting of the College on Problems of Drug Dependence (http://www.cpdd.vcu.edu/Media/Meetings/2005Abstracts/2005AbstractBook.pdf
32. Navarro HA, Howard JL, Pollard GT, and Carroll FI (2009) Positive allosteric modulation of the human cannabinoid (CB) receptor by RTI-371, a selective inhibitor of the dopamine transporter. Br J Pharmacol 156:1178-1184
33. Nguyen VH, Kassiou M, Johnston GA, and Christie MJ (1996) Comparison of binding parameters of sigma 1 and sigma 2 binding sites in rat and guinea pig brain membranes: novel subtype-selective trishomocubanes. Eur J Pharmacol 311:233-240
34. Penmatsa A, Wang KH, and Gouaux E (2013) X-ray structure of dopamine transporter elucidates antidepressant mechanism. Nature 503:85-90
35. Reith ME, Berfield JL, Wang LC, Ferrer JV, and Javitch JA (2001) The uptake inhibitors cocaine and benztropine differentially alter the conformation of the human dopamine transporter. J Biol Chem 276:29012-29018
36. Richelson E (1981) Tricyclic antidepressants: interactions with histamine and muscarinic cholinergic receptors, in Antidepressants: Neurochemical, Behavioral, and Clinical Perspectives (Enna SJ, Malick JB, and Richelson E, eds) pp 53-73, Raven, New York
37. Ritz MC, Lamb RJ, Goldberg SR, and Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-Administration of cocaine. Science 237:1219-1223
38. Scheffel U, Pögün S, Stathis M, Boja JW, and Kuhar MJ (1991) In vivo labeling of cocaine binding sites on dopamine transporters with [3H]WIN 35,428. J Pharmacol Exp Ther 257:954-958
39. Schenk S (2002) Effects of GBR 12909, WIN 35,428 and indatraline on cocaine selfadministration and cocaine seeking in rats. Psychopharmacology (Berl) 160: 263-270
40. Snedecor G and Cochran W eds (1967) Statistical Methods. 6th ed. Ames, Iowa State College
41. Stathis M, Scheffel U, Lever SZ, Boja JW, Carroll FI, and Kuhar MJ (1995) Rate of binding of various inhibitors at the dopamine transporter in vivo. Psychopharmacology (Berl) 119:376-384
42. Tanda G and Katz JL (2007) Muscarinic preferential M(1) receptor antagonists enhance the discriminative-stimulus effects of cocaine in rats. Pharmacol Biochem Behav 87:400-404
43. Tanda G, Li SM, Mereu M, Thomas AM, Ebbs AL, Chun LE, Tronci V, Green JL, Zou MF, and Kopajtic TA, et al. (2013) Relations between stimulation of mesolimbic dopamine and place conditioning in rats produced by cocaine or drugs that are tolerant to dopamine transporter conformational change. Psychopharmacology (Berl) 229:307-321
44. Tanda G, Newman AH, Ebbs AL, Tronci V, Green JL, Tallarida RJ, and Katz JL (2009a) Combinations of cocaine with other dopamine uptake inhibitors: assessment of additivity. J Pharmacol Exp Ther 330:802-809
45. Tanda G, Newman AH, and Katz JL (2009b) Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors. Adv Pharmacol 57:253-289
46. Taylor D and Ho BT (1978) Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine. Res Commun Chem Pathol Pharmacol 21:67-75
47. Zimmer A, Zimmer AM, Hohmann AG, Herkenham M, and Bonner TI (1999) Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci USA 96:5780-5785.